New York, New York, United States The venture was found in North America in United States. The main department of described VC is located in the New York.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the KBL Healthcare Ventures, startups are often financed by ONSET Ventures, Investor Growth Capital Limited, Three Arch Partners. The meaningful sponsors for the fund in investment in the same round are ONSET Ventures, Investor Growth Capital Limited, InterWest Partners. In the next rounds fund is usually obtained by Three Arch Partners, ONSET Ventures, Investor Growth Capital Limited.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from KBL Healthcare Ventures the average startup value is 10-50 millions dollars. The important activity for fund was in 2000. The higher amount of exits for fund were in 2012. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this KBL Healthcare Ventures works on 24 percentage points more the average amount of lead investments.
We also calculated 4 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight EpiCept Corporation, EpiCept Corporation, Remon Medical Technologies. Among the most popular fund investment industries, there are Consumer, Biotechnology. The fund has no exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AOI Pro. | - |
| Atlantica Ventures | Lagos, Lagos, Nigeria |
| Bank of Kochi | Japan, Kochi, Kochi Prefecture |
| Beilun ZhongGang ZhuangShi | China, Ningbo, Zhejiang |
| Bridgestone Corporation | Chiyoda, Japan |
| Changan Assets | China, Shanghai |
| East Wind Capital | - |
| Educational Testing Service (ETS) | New Jersey, Princeton, United States |
| FourthGreen Capital | Incline Village, Nevada, United States |
| JFE Engineering | Chiyoda, Japan |
| Lead Wealth Capital | China, Shanghai |
| Magenta Partners | England, London, United Kingdom |
| NetGain Development | New York, New York, United States |
| NStar | Dallas, Texas, United States |
| Orient Corporation | Chiyoda, Japan |
| Pirelli | Italy, Lombardia, Milano |
| Shenzhen Bingchuan Network | China, Guangdong, Tianjin |
| Times-7 | New Zealand, Wellington, Wellington |
| TLC Capital | Atlanta, Georgia, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CardioFocus | $30M | 28 Feb 2011 | Marlborough, Massachusetts, United States | ||
PneumRx | $27M | 06 Mar 2007 | Mountain View, California, United States | ||
Neuronetics | $35M | 17 Aug 2006 | Pennsylvania, United States | ||
PneumRx | $10M | 14 Jun 2005 | Mountain View, California, United States | ||
Scandius BioMedical | $8M | 23 Feb 2005 | Colorado, United States | ||
Remon Medical Technologies | $10M | 10 Jan 2005 | North District | ||
Remon Medical Technologies | $16M | 24 Sep 2004 | North District | ||
Scandius BioMedical | $4M | 20 Jan 2004 | Colorado, United States | ||
Neuronetics | $15M | 15 Apr 2003 | Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CardioFocus | $30M | 28 Feb 2011 | Marlborough, Massachusetts, United States | ||
PneumRx | $27M | 06 Mar 2007 | Mountain View, California, United States | ||
Neuronetics | $35M | 17 Aug 2006 | Pennsylvania, United States | ||
PneumRx | $10M | 14 Jun 2005 | Mountain View, California, United States | ||
Scandius BioMedical | $8M | 23 Feb 2005 | Colorado, United States | ||
Remon Medical Technologies | $10M | 10 Jan 2005 | North District | ||
Remon Medical Technologies | $16M | 24 Sep 2004 | North District | ||
Scandius BioMedical | $4M | 20 Jan 2004 | Colorado, United States | ||
Neuronetics | $15M | 15 Apr 2003 | Pennsylvania, United States |
